Page last updated: 2024-09-03

rmi 12330a and calcimycin

rmi 12330a has been researched along with calcimycin in 1 studies

Compound Research Comparison

Studies
(rmi 12330a)
Trials
(rmi 12330a)
Recent Studies (post-2010)
(rmi 12330a)
Studies
(calcimycin)
Trials
(calcimycin)
Recent Studies (post-2010) (calcimycin)
14102411,94640444

Protein Interaction Comparison

ProteinTaxonomyrmi 12330a (IC50)calcimycin (IC50)
XBP1Homo sapiens (human)1.41
DNA damage-inducible transcript 3 proteinMus musculus (house mouse)0.16

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chu, MM; Lee, EK; Lin, HR; Wong, AO; Xiao, D1

Other Studies

1 other study(ies) available for rmi 12330a and calcimycin

ArticleYear
Regulation of growth hormone release in common carp pituitary cells by pituitary adenylate cyclase-activating polypeptide: signal transduction involves cAMP- and calcium-dependent mechanisms.
    Neuroendocrinology, 2002, Volume: 76, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Calcimycin; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Carps; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activators; Enzyme Inhibitors; Growth Hormone; Imines; In Vitro Techniques; Ionophores; Isoquinolines; Neuropeptides; Neurotransmitter Agents; Nifedipine; Phosphodiesterase Inhibitors; Pituitary Adenylate Cyclase-Activating Polypeptide; Pituitary Gland; Signal Transduction; Sulfonamides; Vasoactive Intestinal Peptide

2002